Join
Live feed
·
NEWSReleasevia Quantisnow
Aridis Pharmaceuticals Inc. logo

HC Wainwright & Co. Maintains Buy on Aridis Pharmaceuticals, Lowers Price Target to $2

ByQuantisnow·Wall Street's wire, on your screen.
ARDS· Aridis Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ARDS (Aridis Pharmaceuticals Inc.) and more on Quantisnow.